Trials / Completed
CompletedNCT05604365
FearLess in Cognitively Intact Patients With Glioma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Virginia Commonwealth University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study will assess the preliminary feasibility and acceptability of FearLess, a newly-developed psychological intervention for fear of cancer recurrence (FCR) among cognitively-intact patients with glioma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | FearLess Intervention | 8-12 weekly telehealth sessions one hour in length.The intervention includes psychotherapy techniques varying from relaxation response to self-regulation targeted to the specific fears of patients with glioma. |
Timeline
- Start date
- 2022-11-07
- Primary completion
- 2023-11-14
- Completion
- 2023-11-14
- First posted
- 2022-11-03
- Last updated
- 2024-02-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05604365. Inclusion in this directory is not an endorsement.